Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VSTM
VSTM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VSTM News
VS-7375 Demonstrates Strong Efficacy in Cancer Models
Mar 17 2026
Newsfilter
Verastem Presents New Data from LGSOC Clinical Trial at SGO 2026
Mar 17 2026
Newsfilter
Verastem Reports Q4 Earnings Beat, Stock Rises
Mar 05 2026
stocktwits
Verastem Q4 2025 Earnings Call Highlights
Mar 05 2026
seekingalpha
Verastem Q4 Earnings Beat Expectations
Mar 04 2026
seekingalpha
Verastem to Announce Q4 Earnings on March 4
Mar 03 2026
seekingalpha
Verastem Oncology to Host Q4 2025 Financial Results Call
Feb 18 2026
Businesswire
Verastem Oncology Schedules Q4 2025 Financial Results Call
Feb 18 2026
Newsfilter
Verastem Projects $17.5 Million Net Revenue for Q4 2025
Feb 04 2026
seekingalpha
Verastem Projects $30.9M Revenue for 2025 with Key Product Developments
Feb 04 2026
Newsfilter
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
PRnewswire
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
Newsfilter
Verastem Discontinues RAMP 203 Trial, Shifts Focus to VS-7375
Jan 02 2026
Benzinga
TEN Holdings Inc. Raises $2.25M in Private Placement, Shares Surge 17%
Dec 30 2025
Benzinga
Verastem Discontinues RAMP 203 Clinical Trial for Treatment
Dec 29 2025
Yahoo Finance
Verastem Discontinues RAMP 203 Trial to Focus on VS-7375 Development
Dec 29 2025
Newsfilter
Show More News
